Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Baird Downgrades Applied Industrial to Neutral, Announces $129 Price Target

Baird analyst David Manthey downgrades Applied Industrial (NYSE:AIT) from Outperform to Neutral and announces $129 price target.
byBenzinga Newsdesk
August 12, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Baird analyst David Manthey downgrades Applied Industrial (NYSE:AIT) from Outperform to Neutral and announces $129 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Synthetic Biologics Announces Phase I Study To Evaluate The Safety, Tolerability, And Efficacy Of VCN-01 In Combination With Durvalumab In Subjects With Recurrent/ Metastatic Squamous Cell Carcinoma Of The Head And Neck Was Presented At The ESMO Congre…

By Benzinga Newsdesk
September 12, 9:22 AM
Key data and conclusions featured in the Poster Presentation include:     · Safety: Treatment with VCN-01 had an acceptable safety profile when administered with durvalumab in the

SYN